Rick Matthews/LikedIn
Mar 9, 2026, 13:49
Rick Matthews: Looking Beyond Clot Clearance in Long-Term Management After DVT
Rick Matthews, Senior Vascular Consultant at Argon Medical Devices, Inc., shared on LinkedIn:
”We talk a lot about ‘clearing clot today’ with modern mechanical thrombectomy/PMT options, but the long game is what patients live with: recurrent ipsilateral DVT risk, valve injury, chronic outflow obstruction, and structured follow-up.
Are you routinely documenting Villalta at 3–6 months after DVT (and repeating at ~12 months), or is it still inconsistent across services?
PTS symptoms often reflect the net effect of obstruction plus reflux plus microvascular injury—so the pathway has to be stepwise.
My simple escalation triggers (baked into any VTE program):
- Villalta ≥10 / meaningful functional limitation
- Venous claudication
- Skin changes or ulcer
- New/worsening swelling – rule out recurrent DVT first”
Stay updated with Hemostasis Today.
-
Mar 9, 2026, 13:55Marios Georgakis: GLP-1 Receptor Agonism as a Promising Approach for cSVD
-
Mar 9, 2026, 13:54Ahmed Ibrahim: Optimal Antithrombotic Therapy for Secondary Stroke Prevention in Patients with AF and ASCVD
-
Mar 9, 2026, 13:43Genetic Technologies for Hemophilia Information Sheet Now Available in French and Spanish – WFH
-
Mar 9, 2026, 13:38Challenges in Hemophilia Care and Access to Treatment in Pakistan – Hemophilia Welfare Society Karachi Pakistan
-
Mar 9, 2026, 05:13Nicola Hancock: Shaping the Future of Stroke Care and the Stroke Action Plan for Europe at ELASF 2026
-
Mar 8, 2026, 16:19Simon Senanu: Crossmatch Procedures and Advanced Troubleshooting
-
Mar 8, 2026, 15:53Stuart Diamond: ApoB as a Key Marker of Cardiovascular Risk
-
Mar 8, 2026, 15:49Wolfgang Miesbach: Discussing Immunological Challenges in Hemophilia at GTH 2026
-
Mar 8, 2026, 15:41George Sands: AI Screening Tool for Early Detection of Heart Disease